EVs from activated CD8+ T cells were shown to activate ERK and NF-κB in melanoma cells, leading to increased MMP9 expression and promoting cancer cell invasion in vitro, suggesting a role for T cell-derived vesicles in tumor progression (116). Here, CD8A is linked to cancer.